Effects of Magnesium Oxide on Clinical Equivalence of Rosuvastati
Not Applicable
Recruiting
- Conditions
- hyperlipidaemia
- Registration Number
- JPRN-UMIN000025610
- Lead Sponsor
- Fukuoka University Chikushi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients who is not be able to sign the consent (2)Patient that it was judged that drug management in being at home had a problem by the principal investigator or subinvestigator (3)Patients receiving drugs both aluminum and magnesium (4)Other patients judged inappropriate by the principal investigator or subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method As the primary end point, we examined the rate of change in the LDL-C level after 12 weeks in patients achieving a compliance of more than 80% based on compliance-checking sheets.
- Secondary Outcome Measures
Name Time Method